These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14141577)

  • 1. STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).
    VONKA V; TARABCAK M; JANDA Z
    Arch Gesamte Virusforsch; 1964; 14():169-76. PubMed ID: 14141577
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTIGENIC DIFFERENTIATION OF POLIOVIRUSES BY ABSORBED HYPERIMMUNE SERA. I. ANTIGENIC DIFFERENTIATION OF TYPE I STRAINS OF DIVERSE ORIGIN.
    EYLAN E; FOGEL A; DUKLER R; RANNON L
    J Immunol; 1965 Jul; 95():171-80. PubMed ID: 14328695
    [No Abstract]   [Full Text] [Related]  

  • 4. ANTIBODY RESPONSE TO TYPE 1 ORAL POLIO VACCINE.
    PETERSEN I; VONMAGNUS H
    Acta Pathol Microbiol Scand; 1964; 62():331-9. PubMed ID: 14227876
    [No Abstract]   [Full Text] [Related]  

  • 5. [DYNAMICS OF RISE IN THE TITER OF NEUTRALIZING ANTIBODIES IN CHILDREN VACCINATED WITH SABIN'S LIQUID DRIED TRIVALENT ANTIPOLIOMYELITIS VACCINE IN THE BAISUN REGION OF THE SURKHANDAR'IN AREA OF THE UZBEKISTAN SSR].
    ALIMUKHAMEDOV RK
    Med Zh Uzb; 1963 Jul; 8():55-60. PubMed ID: 14081025
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT].
    BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF
    Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261
    [No Abstract]   [Full Text] [Related]  

  • 7. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 8. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 9. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic segregation of type 2 poliovirus isolants related and unrelated to Sabin's vaccine strain with modified Wecker technique.
    Nakano JH; Cole JT
    Am J Epidemiol; 1970 Mar; 91(3):317-27. PubMed ID: 4313253
    [No Abstract]   [Full Text] [Related]  

  • 11. [EXPERIENCES WITH A NEW ATTENUATED POLIOVIRUS TYPE 3 USOL-D BAC DEVELOPED IN CZECHOSLOVAKIA].
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H; ADAMOVA V; STAREK M
    Cesk Epidemiol Mikrobiol Imunol; 1964 Nov; 13():358-69. PubMed ID: 14241623
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on the administration of Mexaform in the course of anti-poliomyelitis vaccination with Sabin's attenuated virus].
    Crovari P; Bori D
    Minerva Med; 1967 Apr; 58(33):1497-502. PubMed ID: 6026631
    [No Abstract]   [Full Text] [Related]  

  • 13. THERMORESISTANCE TESTING FOR IDENTIFICATION OF LSC 2AB VIRUS PROGENY.
    JANDA Z; VONKA V
    Arch Gesamte Virusforsch; 1964; 14():227-37. PubMed ID: 14141582
    [No Abstract]   [Full Text] [Related]  

  • 14. CYTOLOGY OF THE URINE IN CHILDREN AFTER ORAL POLIOVIRUS VACCINE.
    HART AF; CHERRY JD
    N Engl J Med; 1965 Jan; 272():174-9. PubMed ID: 14222016
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibody status one year after the completion of a cycle of immunization with Sabin's oral poliomyelitis vaccine].
    Assumma M; Russo V; Alemanno A
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):175-86. PubMed ID: 5615073
    [No Abstract]   [Full Text] [Related]  

  • 16. COMPLEMENT-FIXING ANTIBODY RESPONSE AFTER ADMINISTRATION OF INACTIVATED AND ORAL POLIOVIRUS VACCINES.
    ZAVADOVA H; ZACEK K; VONKA V
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():487-94. PubMed ID: 14114944
    [No Abstract]   [Full Text] [Related]  

  • 17. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal IgA neutralizing antibodies in newborn infants following poliovirus immunization.
    Keller R; Dwyer JE; Oh W; D'Amodio M
    Pediatrics; 1969 Mar; 43(3):330-8. PubMed ID: 4180265
    [No Abstract]   [Full Text] [Related]  

  • 19. THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. IV. NORMAL ANTIBODY AND EARLY IMMUNE ANTIBODY OF RABBIT ORIGIN: A COMPARISON OF BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES.
    SVEHAG SE
    J Exp Med; 1964 Apr; 119(4):517-35. PubMed ID: 14151096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. II. PRODUCTION OF NEUTRALIZING ANTIBODIES FOLLOWING THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    OGAWA M; KANNO T; URASAWA S
    Sapporo Igaku Zasshi; 1963 Mar; 23():202-9. PubMed ID: 14057343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.